STOCK TITAN

Healthcare Services Group (NASDAQ: HCSG) director elects DSU fee compensation

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Simmons Kurt JR reported acquisition or exercise transactions in this Form 4 filing.

Healthcare Services Group Inc. director Kurt JR Simmons reported receiving 809 shares of common stock as a grant under the company’s 2020 Omnibus Incentive Plan. The award reflects an election to take board fees in fully vested Deferred Stock Units (DSUs) valued at $18.55 per share.

After this grant, Simmons holds 28,190 DSUs, consisting of 2,806 unvested DSUs and 25,384 vested DSUs. These DSUs will be settled in shares of common stock on the earlier of January 1, 2031, death, disability, separation from service, or a Change of Control, with an option for further deferral under Code Section 409A.

Positive

  • None.

Negative

  • None.
Insider Simmons Kurt JR
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 809 $18.55 $15K
Holdings After Transaction: Common Stock — 28,190 shares (Direct)
Footnotes (1)
  1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines. The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock on the first to occur of (i) January 1, 2031; (ii) the Participant's date of death, disability or separation from service; or (iii) the date of a Change of Control (the "Settlement Date"). The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A. Amount represents 2,806 unvested DSUs and 25,384 vested DSUs.
Stock award size 809 shares Grant of common stock/DSUs for board fees
Grant valuation price $18.55 per share Issuer’s closing stock price used to calculate DSUs
Total DSUs held 28,190 units Holdings following the reported grant
Unvested DSUs 2,806 units Portion of DSUs that remain unvested
Vested DSUs 25,384 units Portion of DSUs that are vested
Earliest standard settlement date January 1, 2031 First scheduled DSU settlement date absent earlier events
Deferred Stock Units financial
"fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
2020 Omnibus Incentive Plan financial
"under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees"
blackout period guidelines regulatory
"election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines"
Change of Control financial
"separation from service; or (iii) the date of a Change of Control (the "Settlement Date")"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
Code Section 409A regulatory
"may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Simmons Kurt JR

(Last)(First)(Middle)
3220 TILLMAN DRIVE
SUITE 300

(Street)
BENSALEM PENNSYLVANIA 19020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026A809A$18.55(1)28,190(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines. The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock on the first to occur of (i) January 1, 2031; (ii) the Participant's date of death, disability or separation from service; or (iii) the date of a Change of Control (the "Settlement Date"). The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.
2. Amount represents 2,806 unvested DSUs and 25,384 vested DSUs.
Remarks:
Michael Harrity, by Power of Attorney04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HCSG director Kurt JR Simmons report?

Kurt JR Simmons reported receiving 809 shares of common stock as a stock award. The grant reflects an election to take board fees in fully vested Deferred Stock Units, valued at $18.55 per share, under Healthcare Services Group’s 2020 Omnibus Incentive Plan.

How many Healthcare Services Group (HCSG) DSUs does Kurt JR Simmons now hold?

Following the reported grant, Simmons holds 28,190 Deferred Stock Units tied to Healthcare Services Group common stock. This total includes 2,806 unvested DSUs and 25,384 vested DSUs, representing equity-based compensation for his service on the company’s board and committees.

When will Kurt JR Simmons’s HCSG Deferred Stock Units be settled?

The DSUs will be settled in Healthcare Services Group common stock at the earliest of January 1, 2031, Simmons’s death, disability, separation from service, or a Change of Control. He may also elect an additional deferral period under the rules of Internal Revenue Code Section 409A.

How was the number of 809 HCSG shares in the award calculated?

The 809-share award equals the director’s cash fees divided by Healthcare Services Group’s closing stock price on the payment date. This quotient is then rounded up to the nearest whole share, converting cash compensation into fully vested Deferred Stock Units under the 2020 Omnibus Incentive Plan.

What is the nature of the HCSG Form 4 transaction for Kurt JR Simmons?

The Form 4 transaction is classified as a grant or award acquisition of common stock, not an open-market trade. It reflects routine equity compensation in the form of Deferred Stock Units that replace cash fees for Simmons’s board and committee service at Healthcare Services Group.